CHRS - Coherus Biosciences, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - CHRS (1512762)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
20 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S10-0-3-6+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2018-09-10
CHRSFinck Barbara KChief Medical OfficerS - Sale+OE$18.58-1,76037,043-5%-$32,699
2018-08-29
CHRSHealy JamesDirS - Sale$20.50-25,0002,868,221-1%-$512,500
D
2018-08-13
CHRSFinck Barbara KChief Medical OfficerS - Sale+OE$19.02-1,76037,043-5%-$33,480
2018-07-23
CHRSViret Jean-FredericCFOS - Sale$18.56-9,2913,779-71%-$172,472
DM
2018-07-09
CHRSFinck Barbara KChief Medical OfficerS - Sale+OE$15.01-1,76037,043-5%-$26,415
D
2018-06-18
CHRSFinck Barbara KChief Medical OfficerS - Sale+OE$15.00-1,76037,043-5%-$26,400
2018-05-16
CHRSLanfear Dennis MSee RemarksS - Sale$16.26-20,9841,496,166-1%-$341,265
2017-08-08
CHRSHerman Alan C.Chief Scientific OfficerS - Sale$15.02-17,535349,815-5%-$263,300
2017-07-05
CHRSHerman Alan C.Chief Scientific OfficerS - Sale$15.00-600367,3500%-$9,000
2017-06-01
CHRSHerman Alan C.Chief Scientific OfficerS - Sale$20.32-11,333367,950-3%-$230,292
2017-05-01
CHRSHerman Alan C.Chief Scientific OfficerS - Sale$20.00-11,333379,283-3%-$226,626-10
2017-04-03
CHRSHerman Alan C.Chief Scientific OfficerS - Sale$20.73-11,333390,616-3%-$234,985-1-4-1
2017-03-01
CHRSHerman Alan C.Chief Scientific OfficerS - Sale$24.19-11,333401,949-3%-$274,171-3-8-17
2017-02-01
CHRSHerman Alan C.Chief Scientific OfficerS - Sale$27.37-11,333413,282-3%-$310,155-1-14-9
D
2017-01-25
CHRSViret Jean-FredericCFOS - Sale+OE$27.00-3,9002,992-57%-$105,300+1-3-18
2017-01-03
CHRSHerman Alan C.Chief Scientific OfficerS - Sale$27.95-11,333424,615-3%-$316,7220-3-3
D
2016-12-16
CHRSViret Jean-FredericCFOS - Sale+OE$28.30-3,9002,992-57%-$110,36500-7
M
2016-12-07
CHRSWahlstrom MatsDirS - Sale$27.52-53,583578,528-8%-$1,474,677-1-1-1
2016-12-01
CHRSHerman Alan C.Chief Scientific OfficerS - Sale$27.40-11,333435,948-3%-$310,52300+3
D
2016-11-18
CHRSViret Jean-FredericCFOS - Sale+OE$28.19-3,9002,325-63%-$109,955+10+1
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top